Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listGrowth hormone releasing peptide

Growth hormone releasing peptide

Synonym(s):GHRP-6

  • CAS NO.:87616-84-0
  • Empirical Formula: C46H56N12O6
  • Molecular Weight: 873.01
  • MDL number: MFCD00872694
  • EINECS: 212-729-3
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-07-25 20:04:51
Growth hormone releasing peptide Structural

What is Growth hormone releasing peptide?

Description

Growth hormone-releasing peptides (GHRPs) are synthetic, non-natural peptides endowed with potent stimulatory effects on somatotrope secretion in animals and humans. They have no structural homology with GHRH and act via specific receptors present either at the pituitary or the hypothalamic level both in animals and in humans.

The Uses of Growth hormone releasing peptide

Growth hormone releasing peptide-6 can promote the secretion of growth hormone, regulate food intake, increase weight, and promote animal growth.

The Uses of Growth hormone releasing peptide

L-Histidyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide is a growth hormone releasing peptide.

Benefits

When Growth hormone releasing peptide is administered, a selective pulse is sent to the brain that stimulates the hypothalamus and anterior pituitary to release growth hormones. Once this pulse is sent, the cells go directly to the muscle to support development while staying clear of any possible bone or cartilage growth. When the Peptide is injected it increases cell synthesis, elevates secretion levels of insulin from pancreatic tissue, and increases ghrelin in the stomach—which helps release GH and control hunger. All of these functions work to promote fat loss, shuttling of nutrients, and building clean muscle mass.

Mechanism of action

Growth hormone releasing peptide is generally accepted that GHRPs stimulate the release of GH by acting at the level of the pituitary through a receptor different to that for the endogenous GH-releasing hormone (GHRH). In addition, it has been reported that there are specific binding sites for these peptides in the hypothalamus and that systemic administration of GHRPs increases the expression of the immediate early gene c-fos in a subpopulation of hypothalamic neurons.

Side Effects

Carpal tunnel syndrome.Increased insulin resistance.
Type 2 diabetes.
Swelling in the arms and legs (edema)
Joint and muscle pain.
For men, enlargement of breast tissue (gynecomastia).
Increased risk of certain cancers.

Physiological effects

Growth hormone releasing peptide (GHRP) is a cyclase inhibitor that blocks the release of endogenous growth hormone.The peptide acts on both igf-i and somatotrophs, with receptor activity in the hypothalamus.GHRP can be used to increase body weight and control obesity.It has been shown to stimulate cell division and inhibit apoptosis in vitro.

Solubility in water

It is recommended to reconstitute the lyophilized growth hormone releasing peptide in sterile 18MΩ-cm H2O not less than 100 μg/ml, which can then be further diluted to other aqueous solutions.

storage

Lyophilized Growth hormone releasing peptide although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution Growth hormone releasing peptide should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.

Properties of Growth hormone releasing peptide

Melting point: >160o C (Dec.)
Boiling point: 1407.0±65.0 °C(Predicted)
Density  1.333±0.06 g/cm3(Predicted)
storage temp.  −20°C
solubility  Methanol (Slightly), Water (Slightly)
form  Solid
pka 13.42±0.46(Predicted)
color  White to Off-White
CAS DataBase Reference 87616-84-0(CAS DataBase Reference)

Safety information for Growth hormone releasing peptide

Signal word Warning
Pictogram(s)
ghs
Exclamation Mark
Irritant
GHS07
GHS Hazard Statements H302:Acute toxicity,oral
H315:Skin corrosion/irritation
H319:Serious eye damage/eye irritation
H335:Specific target organ toxicity, single exposure;Respiratory tract irritation
Precautionary Statement Codes P261:Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

Computed Descriptors for Growth hormone releasing peptide

InChIKey WZHKXNSOCOQYQX-FUAFALNISA-N
SMILES C(N)(=O)[C@H](CCCCN)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CC1C2=C(C=CC=C2)NC=1)NC(=O)[C@H](C)NC(=O)[C@@H](CC1C2=C(C=CC=C2)NC=1)NC(=O)[C@H](CC1N=CNC=1)N

Related products of tetrahydrofuran

You may like

  • [D-Trp7, Ala8, D-Phe10]-α-Melanocyte Stimulating Hormone Amide Fragment 6-11 CAS 87616-84-0
    [D-Trp7, Ala8, D-Phe10]-α-Melanocyte Stimulating Hormone Amide Fragment 6-11 CAS 87616-84-0
    87616-84-0
    View Details
  • ethyl 2-formylthiazole-4-carboxylate 73956-17-9 99%
    ethyl 2-formylthiazole-4-carboxylate 73956-17-9 99%
    73956-17-9
    View Details
  • Tubulysin D 99%
    Tubulysin D 99%
    309935-57-7
    View Details
  • Methyl (2R)-2-amino-3-[(triphenylmethyl)sulfanyl]propanoate 58885-35-1 99%
    Methyl (2R)-2-amino-3-[(triphenylmethyl)sulfanyl]propanoate 58885-35-1 99%
    58885-35-1
    View Details
  • (R)-methyl 2-isocyano-3-(tritylthio)propanoate 99%
    (R)-methyl 2-isocyano-3-(tritylthio)propanoate 99%
    View Details
  • Tubulysin G 99%
    Tubulysin G 99%
    799822-08-5
    View Details
  • 205304-87-6 Tubulysin B 99%
    205304-87-6 Tubulysin B 99%
    205304-87-6
    View Details
  • 205304-86-5 99%
    205304-86-5 99%
    205304-86-5
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.